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Abstract
Purpose: This study aimed to compare squamous cell carcinoma (SCC) with inflammatory diseases of the oral and 
maxillofacial region using gallium 67 (67Ga) scintigraphy with computed tomography (CT) and magnetic resonance 
imaging (MRI).
Material and methods: Seventy patients with SCC and 15 patients with inflammatory diseases of the oral and max-
illofacial region underwent 67Ga scintigraphy with CT and MRI. A comparison between imaging features of 67Ga 
scintigraphy, CT, and MRI and lesions was performed with the Pearson’s chi-squared test.
Results: 67Ga scintigraphy was positive for 25 of 39 patients with SCC positive on CT and/or MRI (64.1%) and for 
13 of 15 patients with inflammatory diseases positive on CT and/or MRI (86.7%). The detection of inflammatory 
diseases with 67Ga scintigraphy was higher than that of SCC (p = 0.104).
Conclusions: This study compared SCC with inflammatory diseases of the oral and maxillofacial region using 67Ga 
scintigraphy with CT and MRI. 67Ga scintigraphy is an effective technique for detection of inflammatory diseases of 
the oral and maxillofacial region.
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Introduction
Gallium 67 (67Ga) scintigraphy is a useful adjunct tool 
for differentiation of malignant tumours from benign tu-
mours or inflammatory disease in the oral and maxillofa-
cial region [1]. 67Ga scintigraphy is an effective technique 
for the evaluation of head and neck squamous cell car-
cinoma (SCC), especially tumour recurrence and distant 
metastases [2]. Furthermore, 67Ga single-photon emission 
tomography (SPECT) substantially increases confidence 
in the diagnosis of head and neck tumours when comput-
ed tomography (CT) and/or magnetic resonance imaging 
(MRI) do not permit differentiation between benign and 
malignant disease [3]. However, in recent years, positron 
emission tomography (PET) using the radiolabelled glu-
cose analogue 18F-fluorodeoxyglucose (FDG) has shown 
potential to detect distant metastases [4-7].
Apart from SCC, some authors have reported that 67Ga 
scintigraphy is useful in the differentiation of malignant 
lymphoma [8], sarcoidosis [9-11], and other inflamma-
tory diseases [12,13]. However, to the best of our knowl-
edge, 67Ga scintigraphy with multimodal imaging, such as 
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CT and MRI, for the comparison of SCC and inflamma-
tory diseases of the oral and maxillofacial region has not 
been reported in the literature. The aim of this study was 
to compare SCC with inflammatory diseases of the oral 




The Ethics Committee of our institution approved this 
retrospective study. After providing written, informed 
consent, 85 patients (44 male, 41 female; range age 25-95 
years, mean age 67.0 years; 70 patients with SCC, 15 pa-
tients with inflammatory diseases) underwent 67Ga scin-
tigraphy with CT and MRI at our university hospital from 
July 2013 to February 2018. The histopathological diagno-
ses were obtained by surgery or biopsy in all cases.
Image acquisition
CT imaging was performed with a 16-multidetector CT 
scanner (Aquilion TSX-101A; Canon Medical Systems, 
Otawara, Japan) using the oral and maxillofacial protocol 
at our hospital: tube voltage, 120 kV; tube current, 150 
mAs; field of view, 240 × 240 mm; rotation time, 0.50 sec. 
The protocol consisted of axial acquisition (0.50 mm) 
with axial, coronal, and sagittal multiplanar reformation 
(MPR) images. The patients received contrast-enhanced 
CT (CECT) with non-ionic iodine for head and neck le-
sions. One non-ionic contrast media was used: Iohexol 
300 mgI/ml (Omunipaque 300 Syringe, Daiichi-Sankyo, 
Tokyo, Japan). Contrast medium was administered as 
an injection of 100 ml at a rate of 2.0 ml/s (Autoenhance 
A-250, Nemoto-Kyorindo, Tokyo, Japan).
The MR images (1.5 Tesla MR unit; EXCELART Van-
tage MRT-2003; Toshiba Medical Systems, Otawara, Japan) 
with a head coil included unenhanced axial T1-[repetition 
time (TR) 660 ms, echo time (TE) 12 ms], T2-weighted 
imaging (TR 4000 ms, TE 120 ms), short TI inversion re-
covery images (TR 2500 ms, TE 15 ms, TI 190 ms), as well 
as coronal T1-weighted and T2-weighted imaging. After 
an injection of contrast medium (gadobutrol; Gadovist 
1.0 mol/l Syringe, Bayer, Osaka, Japan; 0.1 ml/kg), axial 
and coronal T1-weighted images (TR 660 ms, TE 12 ms) 
were acquired.
67Ga scintigraphy was obtained with an SNC-5100R 
(Shimadzu, Kyoto, Japan) and a Scintipack 24000 (Shi-
madzu) with a 512 × 512 matrix at 72 hours after the in-
jection; images were recorded on the computer at 6 min/
frame. The radiopharmaceutical used in this study was 
67Ga-citrate (Gallium Citrate-Ga67 Injection, FUJIFILM 
RI Pharma, Tokyo, Japan). Each patient was administered 
the agent at 185 MBq with a rapid intravenous injection. 
The stored data were displayed on a screen for analysis.
Image analysis
For patients with SCC and inflammatory diseases of the 
oral and maxillofacial region, imaging features of 67Ga 
scintigraphy, CT, and MRI were independently analysed 
by two oral and maxillofacial radiologists. Regarding 67Ga 
scintigraphy, images of the lesions were classified into two 
groups1: positive, where the intensity of 67Ga in the lesion 
area was higher than that in the surrounding normal area, 
and negative, where the intensity of 67Ga in the lesion area 
was the same as in the surrounding normal area. Any dis-
crepancies of the imaging evaluation were resolved by 
consensus of the two oral and maxillofacial radiologists.
Statistical analysis
The comparison between imaging features of 67Ga scintig-
raphy, CT, and MRI and lesions was performed with the 
Pearson’s chi-squared test. These analyses were performed 
with the statistical package IBM SPSS Statistics, version 
24 (IBM Japan, Tokyo, Japan). A P value lower than 0.05 
was considered statistically significant.
Results
Regarding cellulitis of the submandibular region (Fig-
ure 1), 67Ga scintigraphy showed increased uptake. Axial 
contrast-enhanced CT (CECT) image showed a mass-
like lesion with heterogeneous enhancement. On MRI, 
axial T1-weighted image (T1WI) revealed homogeneous 
low-signal intensity. Post-contrast T1WI showed heteroge-
neous enhancement. Short TI inversion recovery (STIR) re-
vealed heterogeneous high-signal intensity. Regarding neck 
metastases of SCC (Figures 2, 3), 67Ga scintigraphy showed 
increased uptake. Axial CECT image showed rim enhance-
ment. On MRI, axial T1WI revealed homogeneous low-sig-
nal intensity. Post-contrast T1WI showed rim enhance-
ment. STIR revealed heterogeneous high-signal intensity. 
Furthermore, regarding sialadenitis of the submandibular 
gland (Figure 2) and parotid gland (Figure 3), 67Ga scintig-
raphy showed increased uptake. Axial CECT image showed 
enhancement. On MRI, axial T1WI revealed homogeneous 
low-signal intensity. Post-contrast T1WI showed enhance-
ment. STIR revealed heterogeneous high-signal intensity.
Table 1 shows the comparison between SCC and in-
flammatory diseases of the oral and maxillofacial region 
using 67Ga scintigraphy with CT and MRI. 67Ga scintig-
raphy was positive for 25 of 39 patients with SCC posi-
tive on CT and/or MRI (64.1%), and for 13 of 15 patients 
with inflammatory diseases positive on CT and/or MRI 
(86.7%). The detection of inflammatory diseases with 67Ga 
scintigraphy was higher than that of SCC (p = 0.104).
Discussion
67Ga scintigraphy has been widely used to detect various 
malignant neoplasms, such as SCC [1,3] and malignant 
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Figure 1. Cellulitis of the right side of the submandibular region in a 78-year-old male. 67Ga scintigraphy shows increased uptake in the submandibular region 
(arrow) (A, B). Axial contrast-enhanced CT image shows a mass-like lesion with heterogeneous enhancement in the submandibular region (arrow) (C). On 
MRI, axial T1-weighted image (T1WI) revealed homogeneous low-signal intensity (arrow) (D). Post-contrast T1WI showed heterogeneous enhancement 
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Figure 2. Squamous cell carcinoma of the left side of the tongue in a 39-year-old male. 67Ga scintigraphy shows increased uptake in the submandibular 
region (arrow) (A, B). Axial contrast-enhanced CT image shows a submandibular lymph node with rim enhancement (arrow) and submandibular gland with 
enhancement (arrowheads) (C). On MRI, axial T1WI revealed a submandibular lymph node (arrow) and submandibular gland (arrowheads) with homogeneous 
low-signal intensity (D). Post-contrast T1WI showed a submandibular lymph node with rim enhancement (arrow) and submandibular gland with enhancement 
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Figure 3. Squamous cell carcinoma of the right side of the tongue in a 70-year-old female. 67Ga scintigraphy shows increased uptake in the submandibular 
region (arrow) and buccal region (arrowheads) (A-C). Axial contrast-enhanced CT image shows a submandibular lymph node with rim enhancement (arrow) 
(D). Axial contrast-enhanced CT image shows a parotid gland with heterogeneous enhancement (arrowheads) (E). On MRI, axial STIR revealed parotid gland 
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lymphoma [8] of the head and neck. In our study, 67Ga 
scintigraphy was positive for 25 of 39 patients with SCC 
positive on CT and/or MRI (64.1%). Regarding the mech-
anism of gallium-67 accumulation in tumours, Tsan et al. 
[14] showed that 67Ga was delivered to the tumour through 
capillaries with increased permeability, and 67Ga binding 
proteins might also contribute to the accumulation and re-
tention of 67Ga in tumours. In this study, 67Ga scintigraphy 
was positive for two of 10 patients with tongue SCC posi-
tive on CT and/or MRI (20.0%). We consider that the size 
of tumours is also a factor of the degree of 67Ga accumu-
lation in lesions. However, in recent years, 18F-FDG PET/
CT is crucial for determining treatment strategy because 
it helps to avoid incorrect staging and also provides an ac-
curate assessment of treatment response [4, 6].
In this study, 67Ga scintigraphy was positive for 13 of 
15 patients with inflammatory diseases positive on CT 
and/or MRI (86.7%). Li et al. [1] indicated that 67Ga 
scintigraphy was positive for two of 11 patients who had 
chronic inflammatory lesions (1/4 parotitis, 1/5 submax-
illaritis and 0/2 lymphadenitis) (18.2%). Tsan et al. [14] 
showed that some tumours may be taken up by inflam-
matory cells when they are present. Furthermore, Keijsers 
et al. [9] showed imaging of the inflammatory activity of 
sarcoidosis, namely overall sensitivity to detect active 
sarcoidosis, was 88% for 67Ga imaging. Ishii et al. [10] 
showed that 67Ga scintigraphy was useful in differentiat-
ing between sarcoidosis and IgG4-related disease. Tsai et 
al. [13] suggested that the kidney uptake index from the 
absolute quantitative renal 67Ga scintigraphy may be a use-
ful parameter for evaluating the disease activity in lupus 
nephritis. In this study, the detection of inflammatory dis-
eases with 67Ga scintigraphy was higher than that of SCC 
(p = 0.104). Consequently, the authors consider that 67Ga 
scintigraphy was more useful for inflammatory diseases of 
the oral and maxillofacial region than SCC. Furthermore, 
we recommend 67Ga scintigraphy with multimodal im-
aging, such as CT and MRI, for detection of SCC and in-
flammatory diseases of the oral and maxillofacial region.
There were several limitations of this study. The sam-
ple was relatively small. Therefore, further research is nec-
essary to validate these results.
Conclusions
This study compared SCC with inflammatory diseases of 
the oral and maxillofacial region using 67Ga scintigraphy 
with CT and MRI. 67Ga scintigraphy is an effective tech-
nique for detection of inflammatory diseases of the oral 
and maxillofacial region.
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Table 1. Comparison between squamous cell carcinoma and inflammatory diseases of the oral and maxillofacial region using gallium-67 scintigraphy with 
CT and MRI
Lesions positive 
(number of cases) 
Scintigraphy negative 
CT and/or MRI negative 
Scintigraphy negative 
CT and/or MRI positive 
Scintigraphy
CT and/or MRI positive* 
Inflammatory diseases (15) 0 2 (13.3%)  13 (86.7%)
 Osteoradionecrosis (7) 0 2 (28.6%) 5 (71.4%)
 Cellulitis (4) 0 0 (0%)  4 (100%)
 Medication-related osteonecrosis 
 of the jaw (MRONJ) (3)
0 0 (0%) 3 (100%)
Actinomycosis (1) 0 0 (0%) 1 (100%)
Squamous cell carcinoma (70) 31 14 (35.9%) 25 (64.1%)
Tongue (28) 18 8 (80.0%) 2 (20.0%)
Buccal mucosa (8) 5 1 (33.3%) 2 (66.7%)
Maxilla (8) 2 0 (0%) 6 (100%)
Mandible (6) 2 0 (0%) 4 (100%)
Floor of mouth (3) 3 0 0 
Lip (3) 1 1 (50.0%) 1 (50.0%)
Neck metastases (13) 0 4 (30.8%) 9 (69.2%)
Distant metastases (lung: 1) 0 0 (0%)  1 (100%)
*Inflammatory diseases (86.7%) vs. squamous cell carcinoma (64.1%) (p = 0.104)
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